EARNEST Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

EARNEST Partners’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-205	Closed	-$3K	–	1190
2020 Q4	$3K	Hold	205	–	–	﹤0.01%	961
2020 Q3	$3K	Hold	205	–	–	﹤0.01%	915
2020 Q2	$2K	Sell	205 -80	-28%	-$814	﹤0.01%	959
2020 Q1	$2K	Hold	285	–	–	﹤0.01%	913
2019 Q4	$2K	Hold	285	–	–	﹤0.01%	1020
2019 Q3	$2K	Hold	285	–	–	﹤0.01%	1006
2019 Q2	$2K	Hold	285	–	–	﹤0.01%	1018
2019 Q1	$2K	Hold	285	–	–	﹤0.01%	1026
2018 Q4	$2K	Buy	+285	New	+$2K	﹤0.01%	995

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

EARNEST Partners's RDY Position: Q1 2021 in Review

EARNEST Partners sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 205 shares — an estimated $3K sold.

EARNEST Partners first reported a position in RDY in Q4 2018 and held it in 9 quarters. The position peaked at $3K in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.

EARNEST Partners reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
EARNEST Partners sold 205 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $3K.
EARNEST Partners first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 9 quarters.
EARNEST Partners's Dr. Reddy's Laboratories position peaked at $3K in Q4 2020.
160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.

Based on EARNEST Partners's 13F filing for Q1 2021, filed 17 May 2021.